Top IPOs This Week (July 7-11): High Demand and Big Returns - Should You Buy Now?

The Indian IPO market maintained momentum last week, with several mainboard and SME listings attracting strong investor interest. Some companies saw overwhelming demand, especially from retail and high-net-worth investors.

Crizac Ltd:

Crizac Ltd made a strong debut on the stock market on Wednesday, July 9, listing at Rs 281.05 on the NSE, a 14.7% premium over its IPO price of Rs 245. The stock closed even higher on the first day at Rs 307.60.

The IPO received a huge response, getting oversubscribed nearly 62 times. Qualified Institutional Buyers (QIBs) led with 134x subscription, followed by High Net-Worth Individuals (HNIs) at 76x, and retail investors at 10x.

Crizac was listed on both BSE and NSE, and its last grey market premium (GMP) was Rs 41, suggesting a 15% expected listing gain. However, by Friday, July 11, the stock closed at Rs 328, down 3.07% from the previous close, showing some cooling after the strong debut.

Cryogenic OGS (SME):

Cryogenic OGS (SME) made a strong market debut on July 10, listing at Rs 89.30 on the BSE, a 90% premium over its IPO price of Rs 47.

The SME IPO, worth Rs 17.77 crore, saw massive demand with an oversubscription of 646 times, including 774x by retail investors and 674x by HNIs.

Its last grey market premium (GMP) was Rs 32, indicating a 68% expected listing gain. On July 11, the stock closed higher at Rs 98.44, up 4.99% on the BSE SME platform.

GLEN Industries (SME):

GLEN Industries (SME) IPO saw huge investor demand, getting subscribed 260.28 times by the time it closed on July 10. Retail investors subscribed 225.15 times, QIBs 192.46 times, and NIIs led with 476.25 times.

The IPO was open from July 8 to July 10, 2025. Allotment was finalized on July 11, and the shares are expected to list on the BSE SME on July 15, 2025.

The Rs 63.02 crore IPO had a price band of Rs 97, and the last grey market premium (GMP) was Rs 43, suggesting a likely listing price of around Rs 140 - an expected 44.33% gain.

Who's Invested Where?

"Qualified Institutional Buyers (QIBs) took the lead in larger IPOs like Crizac. Retail investors showed strong interest in SME IPOs such as GLEN and Cryogenic OGS, reflecting their confidence in smaller, fast-growing businesses. High-Net-Worth Individuals (HNIs) were also optimistic, especially about high-growth companies like Cryogenic and Crizac,: noted Bajaj Broking.

Sector Trends:

"Pharmaceutical companies like GLEN, along with industrial packaging firm Cryogenic OGS, led the way in recent IPO activity. The education-tech company Crizac also gained strong interest from institutional investors, mainly due to its plans for global expansion. Overall, the pharma, industrial packaging, and education-tech sectors showed strong performance, with companies focusing on international growth attracting more investor support," according Bajaj Broking report.

What's Driving the Market?

"Favorable macro conditions and lower inflation are helping boost investor confidence. Sector trends are important, pharma and industrials are performing well, while real estate and fintech are staying quiet. Investors are becoming more aware of valuations, being selective and focusing on reasonably priced IPOs with strong growth potential," said Bajaj Broking.

Investor Takeaway:

Cautiously advising the investors, Bajaj Broking said, "The IPO market is thriving, but selectivity is key. With oversubscription rates soaring and GMPs signaling strong listing potential, investors are advised to focus on fundamentals, sectoral tailwinds, and institutional backing. The coming week offers a mix of high-profile and niche opportunities-ideal for both tactical plays and long-term bets."

Disclaimer: The write-up is just for information purposes, and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on article mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.